A commensal symbiosis between Prevotella bivia and Peptostreptococcus anaerobius involves amino acids: potential significance to the pathogenesis of bacterial vaginosis.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 9879923)

Published in FEMS Immunol Med Microbiol on December 01, 1998

Authors

V Pybus1, A B Onderdonk

Author Affiliations

1: Channing Laboratory, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02215, USA.

Articles by these authors

(truncated to the top 100)

Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med (1978) 14.65

Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis (1977) 7.68

Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology (1978) 5.91

Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients. Infect Immun (1978) 3.93

Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun (1974) 3.91

Quantitative bacteriology of the vaginal flora. J Infect Dis (1977) 3.81

The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis (1977) 3.62

Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest (1976) 3.34

Microbial synergy in experimental intra-abdominal abscess. Infect Immun (1976) 3.21

Colitis induced by Clostridium difficile. Rev Infect Dis (1980) 3.15

Structural features of polysaccharides that induce intra-abdominal abscesses. Science (1993) 2.86

Antimicrobial therapy of experimental intraabdominal sepsis. J Infect Dis (1975) 2.56

Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun (1981) 2.34

Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun (1974) 2.33

Clostridium difficile in gnotobiotic mice. Infect Immun (1980) 2.17

Methods for quantitative vaginal flora studies. Am J Obstet Gynecol (1977) 2.05

Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology (1978) 1.98

Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect Immun (1991) 1.95

Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest (1995) 1.91

Neonatal mouse model of group B streptococcal infection. J Infect Dis (1992) 1.82

The role of the intestinal microflora in experimental colitis. Am J Clin Nutr (1977) 1.80

Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr (1979) 1.75

Isolation and identification of encapsulated strains of Bacteroides fragilis. J Infect Dis (1977) 1.74

Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J Infect Dis (1997) 1.71

Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation. Appl Environ Microbiol (1986) 1.67

Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res (1978) 1.66

Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med (1982) 1.62

Effect of dissolved oxygen and Eh and Bacteroides fragilis during continuous culture. Appl Environ Microbiol (1976) 1.62

Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect (1999) 1.57

T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem (2000) 1.57

Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J Immunol (1986) 1.57

Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest (1982) 1.56

Comparison of five regimens for treatment of experimental clindamycin-associated colitis. J Infect Dis (1978) 1.54

Shigella, indigenous flora interactions in mice. Am J Clin Nutr (1972) 1.49

Evaluation of a prereduced anaerobically sterilized medium (PRAS II) system for identification anaerobic microorganisms. J Clin Microbiol (1982) 1.49

Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus. J Immunol (1978) 1.45

Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis (1979) 1.44

Effects of time and growth media on short-chain fatty acid production by Bacteroides fragilis. Appl Microbiol (1975) 1.41

Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. Rev Infect Dis (1981) 1.40

Cervical and vaginal bacterial flora: ecologic niches in the female lower genital tract. Am J Obstet Gynecol (1978) 1.39

Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect Immun (1999) 1.38

Experimental animal models for anaerobic infections. Rev Infect Dis (1980) 1.38

A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg (1978) 1.33

Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus. Infect Immun (1983) 1.28

Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen. J Infect Dis (1980) 1.26

A quantitative model for subcutaneous abscess formation in mice. Br J Exp Pathol (1980) 1.26

Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation. Appl Environ Microbiol (1979) 1.21

Structure-function relationships for polysaccharide-induced intra-abdominal abscesses. Infect Immun (1994) 1.20

Clindamycin-associated colitis in hamsters: protection with vancomycin. Gastroenterology (1977) 1.20

Nugent score related to vaginal culture in pregnant women. Obstet Gynecol (2001) 1.19

Anaerobic microflora of the vagina in children. Am J Obstet Gynecol (1978) 1.18

Production of toxic shock syndrome toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide. Infect Immun (2000) 1.18

Defined medium simulating genital tract secretions for growth of vaginal microflora. J Clin Microbiol (1992) 1.17

Adherence of Bacteroides fragilis in vivo. Infect Immun (1978) 1.17

Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation. J Infect Dis (1977) 1.16

Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity. J Immunol (2000) 1.16

Surface antigens as virulence factors in infection with Bacteroides fragilis. Rev Infect Dis (1980) 1.15

A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J Clin Invest (1985) 1.14

Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis. J Antimicrob Chemother (1979) 1.14

Evaluation of the AnaeroPack system for growth of clinically significant anaerobes. J Clin Microbiol (1997) 1.14

Bacteroides fragilis strains express multiple capsular polysaccharides. J Clin Microbiol (1993) 1.12

IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol (1999) 1.10

Anaerobes in spontaneous peritonitis. Lancet (1977) 1.09

Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol (1998) 1.08

Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation. Infect Immun (1994) 1.07

Effect of surgical adhesion reduction devices on the propagation of experimental intra-abdominal infection. Arch Surg (1999) 1.03

Immunochemical characterization of surface antigens of Bacteroides melaninogenicus. Rev Infect Dis (1980) 1.03

Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infect Immun (1984) 1.00

Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin. J Infect Dis (1977) 0.98

Dogs as sentinels for Lyme disease in Massachusetts. Am J Public Health (1991) 0.97

Will the real Clostridium species responsible for antibiotic-associated colitis please step forward? Lancet (1978) 0.96

Host factors in the formation of abscesses. J Infect Dis (1980) 0.95

Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstet Gynecol (1995) 0.94

The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells. Infect Immun (1996) 0.93

Axonal necrosis of enteric autonomic nerves in continent ileal pouches. Possible implications for pathogenesis of Crohn's disease. Ann Surg (1993) 0.93

A polymeric drug for treatment of inflammatory bowel disease. J Med Chem (1983) 0.90

Anion-exchange resins in antibiotic-associated colitis. Lancet (1978) 0.88

Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model. Scand J Infect Dis Suppl (1982) 0.86

Mixed-effect models for predicting microbial interactions in the vaginal ecosystem. J Clin Microbiol (1994) 0.86

Comparison of Bacteroides vulgatus strains in the enhancement of experimental ulcerative colitis. Infect Immun (1987) 0.86

Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo. Int Arch Allergy Immunol (1993) 0.85

Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs. Infect Immun (1988) 0.84

Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis. Rev Infect Dis (1984) 0.83

The biological and clinical significance of Clostridium difficile. Crit Rev Clin Lab Sci (1981) 0.82

Experimental models for ulcerative colitis. Dig Dis Sci (1985) 0.82

The carrageenan model for experimental ulcerative colitis. Prog Clin Biol Res (1985) 0.82

Human gut mucosal mast cells: ultrastructural observations and anatomic variation in mast cell-nerve associations in vivo. Int Arch Allergy Immunol (1992) 0.81

Immune mechanisms in the prevention of intra-abdominal abscess formation. Scand J Infect Dis Suppl (1989) 0.81

Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide. J Infect Dis (1986) 0.81

Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A. J Clin Pathol (1997) 0.80

Misidentification of mucoid variants of Staphylococcus aureus by standard laboratory techniques. J Clin Microbiol (1985) 0.80

Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis. Rev Infect Dis (1984) 0.79

Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis (1995) 0.79

Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora. Antimicrob Agents Chemother (1975) 0.78

Host-microbe interactions: virulence mechanisms of bacterial pathogens. Science (1988) 0.77

Peritonsillar infection and bacteremia caused by Fusobacterium gonidiaformans. J Pediatr (1974) 0.76

Immune T cells prevent bacteroides fragilis abscesses. Curr Surg (1983) 0.76

T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses. Rev Infect Dis (1990) 0.76

Statistical models for vaginal microflora: identifying women at risk for group B streptococcus colonization as a test of concept. Infect Dis Obstet Gynecol (1997) 0.75

Editorial response to Brook: Comparison of in vivo methods for determination of antimicrobial efficacy. Rev Infect Dis (1992) 0.75